People · Operator
Named in public records as an officer, director or promoter · active 2009–2015 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Oraya Therapeutics Inc | — | Other Technology | Series B | $74.9M | $765.4M | 2009 |
| Kona Medical, Inc. | — | Biotechnology | Series B | $61.6M | $396.9M | 2010 |
Michael Gertner at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Gertner on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Cohn | 2 | 10 |
| Brian Halak | 2 | 10 |
| James Taylor | 1 | 12 |
| Henry A. Plain, Jr. | 1 | 7 |
| Reza Zadno | 1 | 7 |
| Guido Neels | 1 | 7 |
| Immanuel Thangaraj | 1 | 6 |
| Mark Brooks | 1 | 5 |
| Hank Plain | 1 | 5 |
| John Onopchenko | 1 | 4 |
| Louis Cannon | 1 | 3 |
| Christopher A. Shen | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.